Health Policy

Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures. 

Our Mission

The U.S. Chamber of Commerce's Health Policy Division identifies and advances legislative and regulatory policies to - 

  • Increase access to coverage and services

Scope of Issues

Through the Chamber's ability to convene dynamic groups of stakeholders and engage with our diverse member companies, we drive the dialogue and lead strategic partnerships to accomplish the following: 

 

Advocacy

The Chamber educates and advises member companies about key developments in Washington and collaborates with leaders in Congress and federal agencies to further our policy priorities. 

 

Policy Committees and Working Groups

The Health Policy Division represents our members' views by crafting policy positions through the Employee Benefits Committee (EBC), the Health Care Regulatory Task Force, the Supporting Opioid Solutions (SOS) Task Force, the Health Insurer Council, and the Health Policy Advisory Board. 

 

Recent Activity

Issue BriefMar 17, 2020 - 12:45pm

Summary of Latest Congressional Action on Coronavirus Response

Summary of Latest Congressional Action on Coronavirus Response

Letters to CongressMar 13, 2020 - 11:45am

U.S. Chamber Letter on Coronavirus Legislation to Support American Workers and Their Families

This Hill letter was sent to the Members of the United States Congress, on a legislative package intended to help American workers and their families weather the coronavirus pandemic.

Letters to CongressMar 12, 2020 - 12:15pm

U.S. Chamber Letter on Legislation to Address the Coronavirus Pandemic

This Hill letter was sent to the Members of the United States Congress, on legislation to address the coronavirus pandemic.

Letters to CongressMar 04, 2020 - 3:15pm

U.S. Chamber Letter on H.R. 6074, the "Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020"

This Hill letter was sent to the members of the United States Congress, supporting H.R. 6074, the "Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020."

Letters to CongressFeb 14, 2020 - 11:00am

U.S. Chamber Letter Supporting S. 3129, the "Lower Costs, More Cures Act of 2019"

This Hill letter was sent to Senator Mike Crapo and to Members of the United States Senate, supporting S. 3129, the "Lower Costs, More Cures Act of 2019."

Press ReleaseJan 09, 2020 - 10:00am

Donohue: 'Engaging with the world is our best strategy for strong national security and lasting prosperity'

Today U.S. Chamber CEO Thomas J. Donohue cautioned that the United States must continue to engage on the world stage or risk being left behind in his annual State of American Business Address.

Letters to CongressDec 10, 2019 - 1:00pm

U.S. Chamber Key Vote Alert! on H.R. 3, "Lower Drug Costs Now Act"

This Key Vote Alert! letter was sent to the U.S. House of Representatives, opposing H.R. 3, the "Lower Drug Costs Now Act of 2019."

Letters to CongressDec 03, 2019 - 2:30pm

U.S. Chamber Letter on Health Care Pricing Proposals

This Hill letter was sent Congressional Leadership, on several health policy proposals.

EventOct 31, 2019 - 9:00am to 6:00pm
The Business of Health event key graphic

The Business of Health: Transforming with Transparency

During this half-day event we'll examine the dynamics of health care and the people, ideas, and innovations that are leading the way.